𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adriamycin action on human breast cancer cells: Enhancement by medroxyprogesterone acetate

✍ Scribed by Naeem A. Shaikh; Alison M. Owen; Margaret W. Ghilchik; Hannelore Braunsberg


Book ID
102278386
Publisher
John Wiley and Sons
Year
1989
Tongue
French
Weight
446 KB
Volume
43
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Exposure of cultured human breast cancer cells (MCF-7) to medroxyprogesterone acetate (MPA) prior to treatment with adriamycin (ADR) enhanced the effect of the cytotoxic drug on cell yield after further growth of viable cells. Pretreatment with oestradiol (E2) produced similar synergism, but no such effect was observed using dexamethasone. Exposure to ADR before MPA led to an additive effect, but not to synergism. When cells resistant to the growth-inhibitory action of MPA were examined, progestogen/drug synergism could still be demonstrated. We conclude that the effects of ADR, like those of methotrexate and vincristine, can be enhanced by pre-treatment with MPA and that further clinical trials of such a regimen are needed.


πŸ“œ SIMILAR VOLUMES


Actions of medroxyprogesterone acetate o
✍ Naeem A. Shaikh; Alison M. Owen; Margaret W. Ghilchik; Hannelore Braunsberg πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 632 KB

Human breast cancer cells (MCF-7) showed increased responses to methotrexate and vincristine after a 48-hr pretreatment with medroxyprogesterone acetate. The effect of the hormone, which was detectable at concentrations of between 10 and IOOnM, was independent of its growth-inhibitory action. These